GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlaxoSmithKline Plc (GSK) is a healthcare company that focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervous system (CNS), metabolic, cardiovascular and urogenital, anti-bacterials, dermatology and rare diseases. The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSKs vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.

GlaxoSmithKline Plc Key Recent Developments

Mar 21,2019 GlaxoSmithKline targets regulatory filings by year end for antiBCMA drug GSK2857916 in multiple myeloma httpswww.firstwordpharma.comnode1630817 $GSK
Mar 18,2019 Two-drug combos using popular calcium channel blocker show superiority in lowering blood pressure
Mar 11,2019 NEW GENETIC DATA FROM REGENERON AND GSK ON 50,000 UK BIOBANK PARTICIPANTS MADE AVAILABLE TO GLOBAL HEALTH RESEARCH COMMUNITY
Mar 11,2019 New genetic data from Regeneron and GSK on 50,000 UK Biobank participants made available to global health research community

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables
List of Figures
Section 1 - About the Company
GlaxoSmithKline Plc - Key Facts
GlaxoSmithKline Plc - Key Employees
GlaxoSmithKline Plc - Key Employee Biographies
GlaxoSmithKline Plc - Major Products and Services
GlaxoSmithKline Plc - History
GlaxoSmithKline Plc - Company Statement
GlaxoSmithKline Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 Company Analysis
Company Overview
GlaxoSmithKline Plc - Business Description
Business Segment: Consumer Healthcare
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Business Segment: Vaccines
Overview
Performance
Key Stats
Geographical Segment: Rest of World
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
GlaxoSmithKline Plc - Corporate Strategy
GlaxoSmithKline Plc - SWOT Analysis
SWOT Analysis - Overview
GlaxoSmithKline Plc - Strengths
GlaxoSmithKline Plc - Weaknesses
GlaxoSmithKline Plc - Opportunities
GlaxoSmithKline Plc - Threats
GlaxoSmithKline Plc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
GlaxoSmithKline Plc, Recent Deals Summary
Section 5 Companys Recent Developments
Mar 21, 2019: GlaxoSmithKline targets regulatory filings by year end for antiBCMA drug GSK2857916 in multiple myeloma httpswww.firstwordpharma.comnode1630817 $GSK
Mar 18, 2019: Two-drug combos using popular calcium channel blocker show superiority in lowering blood pressure
Mar 11, 2019: NEW GENETIC DATA FROM REGENERON AND GSK ON 50,000 UK BIOBANK PARTICIPANTS MADE AVAILABLE TO GLOBAL HEALTH RESEARCH COMMUNITY
Mar 11, 2019: New genetic data from Regeneron and GSK on 50,000 UK Biobank participants made available to global health research community
Mar 04, 2019: California Life Sciences Association (CLSA) adds GlaxoSmithKline and Blade Therapeutics to Board
Feb 27, 2019: Study Identifies Predictors of Psychiatric Events During Drug-Assisted Smoking Cessation
Feb 18, 2019: GSK to divest Chiron Behring Vaccines to Bharat Biotech
Feb 06, 2019: GSK signs $4.2bn immunotherapy deal with Merck
Feb 06, 2019: GSK delivers sales, earnings and cash flow growth in 2018
Feb 05, 2019: Wellcome commits 10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


GlaxoSmithKline Plc, Key Facts
GlaxoSmithKline Plc, Key Employees
GlaxoSmithKline Plc, Key Employee Biographies
GlaxoSmithKline Plc, Major Products and Services
GlaxoSmithKline Plc, History
GlaxoSmithKline Plc, Other Locations
GlaxoSmithKline Plc, Subsidiaries
GlaxoSmithKline Plc, Joint Venture
GlaxoSmithKline Plc, Key Competitors
GlaxoSmithKline Plc, Ratios based on current share price
GlaxoSmithKline Plc, Annual Ratios
GlaxoSmithKline Plc, Annual Ratios (Cont...1)
GlaxoSmithKline Plc, Annual Ratios (Cont...2)
GlaxoSmithKline Plc, Interim Ratios
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
GlaxoSmithKline Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


GlaxoSmithKline Plc, Performance Chart (2014 - 2018)
GlaxoSmithKline Plc, Ratio Charts
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Enterprise Tech Ecosystem Series - GlaxoSmithKline plc

Enterprise Tech Ecosystem Series - GlaxoSmithKline plcGlaxoSmithKline Plc (GSK) is one of the leading research-based pharmaceutical and healthcare companies in the world. The company is engaged in research, development and

USD 1295 View Report

GlaxoSmithKline Plc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

GlaxoSmithKline Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe GlaxoSmithKline Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Enterprise Tech Ecosystem Series - GlaxoSmithKline plc

Enterprise Tech Ecosystem Series - GlaxoSmithKline plcGlaxoSmithKline Plc (GSK) is one of the leading research-based pharmaceutical and healthcare companies in the world. The company is engaged in research, development and

USD 1295 View Report

GlaxoSmithKline Plc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

GlaxoSmithKline Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe GlaxoSmithKline Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available